We are pleased that Blue Cross Blue Shield of Mississippi has taken steps to comply with federal preventive coverage requirements by adding these two PrEP drugs. The people of Mississippi deserve the same benefits of innovative HIV prevention tools that other people across the country have access to. But by excluding other long-acting medications, which are recommended in national HIV treatment and prevention guidelines, Mississippians are still not able to access these highly effective drugs that improve patient adherence.
House Appropriations calls on CMS to ensure copay assistance counts toward out-of-pocket limits
For years patients have seen manufacturer assistance diverted away from their deductibles and out‑of‑pocket maximums, increasing their costs and forcing impossible choices. We thank the subcommittee for urging CMS to act and call on the agency to promptly issue clear, enforceable guidance so patients actually receive the benefit of assistance meant for them.
House Republicans Propose $1 Billion in Cuts to Domestic HIV Programs
We can’t imagine a country that is unable to conduct basic surveillance of a serious infectious disease, educate and test people, and link them to appropriate treatment or prevention, including PrEP. That is what would happen if the House Republican bill were to pass. Sadly, these proposals will just continue the instability in our nation’s HIV prevention programs, which are primarily conducted at the state and local levels. We urge Congress to reject them, as they did last year.
CMS fails to exempt people living with HIV from Medicaid work requirements
The law is very clear that people who have special medical needs, including those with a serious or complex medical condition, are statutorily exempt from the community engagement requirement. People living with HIV have a lifelong serious and complex medical condition and have special medical needs—they cannot stay healthy without continuous access to lifesaving HIV treatment. Any gap will put them at risk of serious health consequences. We are disappointed that the Trump administration ignored the law and, while they agree that HIV/AIDS and viral hepatitis are serious or complex medical conditions, they are proposing that states will have to determine for every individual if their health is impaired and that they can’t comply with the work requirement. This added requirement was not in the law and puts the health of people living with HIV and viral hepatitis at risk.
New CDC HIV surveillance report demonstrates national response must be accelerated
This data demonstrates that we are not making significant progress in reducing HIV in the United States and efforts to end HIV, unfortunately, remain stalled. Without a jumpstart of resources and a renewed national commitment and leadership by public officials across the country, we are destined to continue to fall short in meeting our goals.